[Ip-health] Federal Register Notice: Facilitating Competition and Innovation in the Biological Products Marketplace; Public Hearing; Request for Comments

James Love james.love at keionline.org
Thu Jul 26 06:07:15 PDT 2018

This seems important.  Jamie


The Food and Drug Administration (FDA or the Agency) is announcing a public
hearing on FDA's approach to enhancing competition and innovation in the
biological products marketplace, including by facilitating greater
availability of biosimilar and interchangeable products.

The public hearing will be held on Tuesday, September 4, 2018, from 9 a.m.
to 5 p.m. The public hearing may be extended or may end early, depending on
the level of public participation. Persons seeking to attend or to present
at the public hearing must register by Tuesday, August 14, 2018. Section
III provides attendance and registration information. Electronic or written
comments will be accepted after the public hearing until Friday, September
21, 2018.

More information about the Ip-health mailing list